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A proportion of the plant's L-ascorbate (vitamin C) occurs in the apoplast, where it and its metabolites
may act as pro-oxidants and anti-oxidants. One ascorbate metabolite is 2,3-diketogulonate (DKG),
preparations of which can non-enzymically generate H2O2 and delay peroxidase action on aromatic
substrates. As DKG itself generates several by-products, we characterised these and their ability to
generate H2O2 and delay peroxidase action.
DKG preparations rapidly produced a by-product, compound (1), with lmax 271 and 251 nm at neutral
and acidic pH respectively. On HPLC, (1) co-eluted with the major H2O2-generating and peroxidase-
delaying principle. Compound (1) was slowly destroyed by ascorbate oxidase, and was less stable at
pH 6 than at pH 1. Electrophoresis of an HPLC-enriched preparation of (1) suggested a strongly acidic (pKa
z 2.3) compound. Mass spectrometry suggested that un-ionised (1) has the formula C6H6O5, i.e. it is a
reduction product of DKG (C6H8O7).
In conclusion, compound (1) is the major H2O2-generating, peroxidase-delaying principle formed non-
enzymically from DKG in the pathway ascorbate/ dehydroascorbic acid/ DKG/ (1). We hypothesise
that (1) generates apoplastic H2O2 (and consequently hydroxyl radicals) and delays cell-wall crosslinking
d both these effects favouring wall loosening, and possibly playing a role in pathogen defence.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
L-Ascorbic acid (C6H8O6; vitamin C) is an important redox
compound in all plants and animals. In plants, it is synthesised in
the protoplast, and a proportion of it is released into the apoplast
(aqueous solution that permeates the cell wall) [11,37], where some
of it is enzymically and non-enzymically oxidised by O2 to form
monodehydroascorbate, which rapidly disproportionates into
ascorbate and dehydro-L-ascorbic acid (DHA; C6H6O6). Ascorbatee; ABTS, 2,20-azino-bis(3-
ascorbate; DKG, 2,3-diketo-L-
orm of 2,3-diketogulono-d-
2,3-diketogulono-d-lactone;
Resources Institute Finland
ki, Finland.
en).
tories, University of Exeter,
r Inc. This is an open access articleoxidase is well established to be a wall-localised enzyme capable of
modulating the ascorbate:DHA ratio [43]. Apoplastic ascorbate and
its downstream metabolites have been widely discussed as
important players in protecting the plant against environmental
oxidative stresses, especially ultraviolet irradiation, atmospheric
ozone pollution and pathogen challenge [4,5,10,40,41,44,47,53].
Apoplastic ascorbate metabolites have also been proposed to serve
roles in modulating the cell wall's biophysical properties, especially
inﬂuencing the softening of ripening fruits and the extensibility of
the primary wall [1,9,12,15,25].
DHA is unstable in neutral aqueous solutions and is easily de-
lactonised to 2,3-diketo-L-gulonic acid (DKG; C6H8O7) which itself
converts non-enzymically to several further degradation products
depending on the incubation conditions [8,26,35,46,51]. In the
apoplast of cultured rose cells, a portion of the DHA is oxidised to
oxalate and L-threonate (and esters thereof), some of these re-
actions being proposed to generate H2O2, and a further portion of
the DHA is hydrolysed to DKG [17,18]. The balance between these
two pathways (oxidation:hydrolysis ratio of DHA) is dictated by the
severity of the ambient oxidising conditions [38,39]. Someunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ology and in pathogen defence because of their unique redox
properties.
DKG is a highly unstable compound, readily forming a wide
range of by-products. Some of the many reported ascorbate
degradation products, probably formed via DKG, include 2,3-
enediol-DKGL (C6H6O6; the 2,3-enediol form of 2,3-diketo-
gulono-d-lactone), 3,4-enediol-DKGL (also C6H6O6; the 3,4-enediol
form of 2,3-diketo-gulono-d-lactone) and L-erythroascorbic acid
(C5H6O5), have reducing activity and might function as reducing
agents in a similar way to ascorbate in vivo [26,27,35,48]. The
pathway from DKG to erythroascorbate was suggested to proceed
via 2,3-enediol-L-lyxose, with O2 (or DHA if present) serving as
oxidant in the conversion of 2,3-enediol-L-lyxose to eryth-
roascorbate [19]. However, the physiological signiﬁcance of eryth-
roascorbate formation fromDKGmay be limited, as the process was
only rapid in the presence of cyanide, 0.5 M phosphate, and a pH of
8.
De-lactonisation of DHA to DKG is often considered to be irre-
versible [35]. However, some formation of DHA by re-lactonisation
of DKG has been demonstrated, especially at lower pH values [31].
DHA can be reduced to ascorbate when a suitable reductant is
present; 3,4-enediol-DKGL formed from DKG was considered to be
this reductant [48]. Indeed, the concentration of 3,4-enediol-DKGL
rose to 10% of that of DKG after 30 min incubation of DKG at neutral
pH in a nitrogen atmosphere [48].
DKG has also been reported to undergo decarboxylation to L-
xylosulose (¼ L-xylosone) [19,32,55], from which erythroascorbate
may be formed [21]. L-Xylosulose may also give rise to several
strongly acidic redox compounds e.g. 2-furoic acid and the de-
lactonised form of 5-methyl-3,4-dihydroxytetrone, although most
of these were only formed under highly unphysiological conditions
such as 0.5 M H2SO4 at 90 C [26]. Non-acidic dioxo products may
be formed from DKG after the loss of oxalate by hydrolysis to form
L-erythrulose and subsequently 3-deoxy-L-threosulose (¼ 3-deoxy-
L-threosone) or after the loss of oxalate by an oxidative pathway to
form L-threosulose d all of which are compounds discussed as
being of relevance to the ageing of animal lens proteins [34].
However, we are not aware of any of these particular dioxo prod-
ucts being reported to delay peroxidase action or to reduce O2 to
H2O2.
Additional products of DKG degradation, formed in the plant
apoplast, include compounds ‘C’ and ‘E’ [17], provisionally identi-
ﬁed [39] as C ¼ 2-carboxy-L-xylonolactone plus 2-carboxy-L-lyx-
onolactone and E ¼ their de-lactonised product; C and E are
interconvertible, but otherwise relatively stable both in vivo and
in vitro.
‘DKG’ preparations have biologically interesting redox proper-
ties, probably due to the formation of DKG degradation products.
An eneediol group or some other functional group that is as easily
oxidisable as an eneediol is thought to be a common feature of the
ascorbate degradation products having reducing properties [51].
For example, ‘DKG’ (120 mM) has been reported to be an anti-
oxidant against the oxidative modiﬁcation of yolk lipoprotein in a
copper-containing solution, whereas it has a pro-oxidative effect at
lower concentrations (75 mM; [29]). Furthermore, ‘DKG’ at
micromolar concentrations delays copper-induced oxidative for-
mation of conjugated dienes in yolk lipoprotein, the lag time
lengthening with increasing ‘DKG’ concentrations [29]. Since DKG
itself has no reducing activity, it was suggested that 3,4-enediol-
DKGL, the most prevalent breakdown product detected, was
responsible for the anti-oxidative effect [29]. 2,3-Enediol-DKGLwas
also present and possibly contributed to the anti-oxidative func-
tion. Likewise, [42] hypothesised that the protective effect of DHA
on copper-induced oxidative modiﬁcation of human low-densitylipoprotein was due to stable modiﬁcation of the protein by DHA
or its breakdown product(s).
‘DKG’ has previously been observed to accelerate the peroxi-
dation of linoleic acid in neutral but not in slightly acidic solutions
[49]. A superoxide-scavenging agent, Tiron, suppressed linoleate
peroxidation whereas catalase had no inhibitory effect, suggesting
that superoxide was the reactive oxygen species (ROS) generated
during incubation with DKG. Although H2O2 was the ROS detected
in the present study, the possibility remains that superoxide was
the original ROS generated, forming H2O2 by dismutation.
Ascorbate induces clear non-enzymic H2O2 generation when
added into a solution containing a transitionmetal [7,12]. Also DHA,
and especially a DKG preparation prepared from commercial DHA,
led to H2O2 generation when added into a solution containing a
trace of copper ions [22]. To detect the H2O2 generated after DKG
addition we used two separate assays: the xylenol orange (XO)
assay [3,16] and an indirect peroxidase activity assay in which o-
dianisidine was used as a peroxidase substrate. Differences in the
results obtained by these twomethods led to the discovery that the
DKG preparation contained a compound that inhibits peroxidase
activity. Since the DKG preparation contained several breakdown
products, as observed by paper electrophoresis followed by silver
staining (Fig. 9 in Ref. [22], wewanted to resolvewhich of thesewas
the major active component inducing non-enzymic H2O2 genera-
tion and delaying peroxidase action.
2. Materials and methods
2.1. Chemicals
Ascorbate oxidase (AAO), 2,20-azino-bis(3-ethylbenzthiazoline-
6-sulphonic acid) (ABTS), catalase, dehydroascorbic acid and
dehydro-L-ascorbic acid dimer, o-dianisidine dihydrochloride and
horseradish peroxidase type II were obtained from Sigma-Aldrich.
AAO was dissolved as a stock at 1000 U ml1 in 50 mM succinate
(Naþ) buffer, pH 5.6, supplemented with 0.05% bovine serum al-
bumin. Peroxidase was dissolved (1 mg ml1) and further diluted in
the same buffer.
DKG was prepared from the commercial DHA by alkali treat-
ment [56]. A stock of DHA (50 mM) was prepared in water (it took
at least 30 min to dissolve DHA). A slight molar excess of NaOH
(1.3  ) was added and the mixture incubated at 20 C for 6 min.
Routinely, the hydrolysis was then stopped with 1 M L-tartaric acid
and the pH was checked by pH paper (~3.5e4.0). However, for
samples to be fractionated by HPLC, hydrolysis was stopped with
1 M H2SO4 to a ﬁnal pH of ~1 or ~6. Freshly-made DHA and DKG
solutions were stored on ice before the assays.
DKG was prepared also by an iodate method [20]. A solution of
ascorbic acid (0.12 M) was incubated with potassium iodate
(0.36 M) for 5 min. KOH (1 M) was then added dropwise until the
solution became colourless. Cold ethanol (8 vol,20 C) was added,
and the precipitated DKG was vacuum ﬁltered, rinsed in 70%
ethanol, dried and stored at 80 C.
2.2. In-vitro peroxidase activity assays
The effects of various ascorbate breakdown products on
peroxidase activity were tested in vitro. DHA and DKG stock solu-
tions were freshly prepared and added at various concentrations to
a reaction mixture (total volume 1.0 ml) that contained either
550 mM ABTS or 800 mM o-dianisidine, and 250 or 500 mM H2O2,
3.13 or 6.25 ng/ml horseradish peroxidase type II and the com-
pound of interest, in 44 mM succinate (Naþ) buffer, pH 5.6. [All
concentrations quoted are ﬁnal, in the complete reaction mixture,
unless otherwise stated.] The reaction was initiated by the addition
Table 1
Ultraviolet absorption properties of ascorbate and some of its degradation products.
Compound lmax at acidic pH (nm) lmax at neutral pH (nm) References
Cmpd (1) 251 271 present work
L-Ascorbate 245 265 [19]
Dehydro-L-ascorbic acida <195 [54]
223 [2,54,59]
225w
2,3-Diketo-L-gulonate <195 <225 [36,54]
L-Erythroascorbate 245 265 [19]
2,3-Enediol-DKGL 210, 300 225, 345 [29,51]
3,4-Enediol-DKGL 245 265 [29,36]
2-Furoic acid 255 245 [26,60]
252
5-Methyl-3,4-dihydroxytetrone 245 265 [26]
L-Erythrulose 279 279 [33]
Oxalate <205 <205
Succinateb <205 <205
w ¼ Weak absorbance maximum.
a Fig. 3a of [21] shows that fresh dehydroascorbic acid has almost no absorbance at ~300 nm, but acquires absorbance at or near that wavelength after lengthy storage of the
solution.
b Not a product of ascorbate catabolism, but used in the present work as a buffer.
A. K€ark€onen et al. / Archives of Biochemistry and Biophysics 620 (2017) 12e2214of the enzyme and followed at 420 and 405 nm for ABTS and o-
dianisidine respectively. When an ascorbate oxidase (AAO) pre-
treatment was included, the compound of interest (~0.5 mM) was
pre-incubated in 4 U/ml AAO and 44mM succinate (Naþ) buffer, pH
5.6, for 10, 15 or 60 min at 20 C before addition of the other assay
components.
2.3. Search for the active component(s) in the DKG preparation that
stimulates H2O2 production and inhibits peroxidases
As the DKG preparation contained several compounds in addi-
tion to DKG (Fig. 9 in Ref. [22], these ‘metabolites’ were separated
by preparative high-voltage paper electrophoresis at pH 2.0, 3.5
and 6.5 according to [14]. Each electrophoretogram was cut into
strips, and the compounds were eluted from the paper in water,
concentrated in vacuo (SpeedVac, Savant) and stored at 75 C. The
effect of eluted compounds on non-enzymic H2O2 production wasFig. 1. Effect of dehydroascorbate and a diketogulonate preparation on the peroxidase react
AAO is also shown (þAAO). DHA, dehydroascorbic acid; DKG, diketogulonate.tested in vitro: 10 ml of each fraction, supplemented with 1 mM
CuSO4, was tested for H2O2 formation by the xylenol orange (XO)
method [3]. The XO method detects hydroperoxides that oxidise
Fe2þ in an acidic solution, and the amount of ferric product is
measured as a XO complex [16]. Also the effect of each fraction on
peroxidase activity in vitro was tested. To conﬁrm the identity and
stability of compounds used in the assays, we re-electrophoresed
each fraction at the original pH, and stained the solutes with
AgNO3 [13].
2.4. Search for the AAO-responsive ‘metabolite’ in the DKG
preparation by HPLC
DKG [4.7 mM, in 45 mM succinate (Naþ) buffer, pH 5.6] was
treated with AAO (12 U/ml) or denatured AAO (10 min boiling) at
25 C for 15 minwith gentle mixing, then the enzymic reactionwas
terminated by addition of H2SO4 to pH ~1. Reaction products,ion with o-dianisidine as substrate. The effect of the DKG preparation pre-treated with
A. K€ark€onen et al. / Archives of Biochemistry and Biophysics 620 (2017) 12e22 15analysed by HPLC, were compared with those in an untreated DKG
aliquot.
2.5. Semi-puriﬁcation of the active compound(s) in DKG
preparation by HPLC
HPLC was used to purify the compound(s) that inhibits peroxi-
dases and generates H2O2 when added into 1 mM Cu2þ. DKG
preparations (~46 mM, pH ~1 and ~6) were ﬁltered (0.4 mm,
Chromacol), and 40 ml was fractionated on a Phenomenex Rezex
ROA column, run (0.5 ml min1) at 35 C, routinely with
47 mM H2SO4 as mobile phase. In some experiments, 13 mM TFA
[0.1% (v/v)] was used when a volatile mobile phase was required.
Degradation products were detected by UV absorbance at various
wavelengths.
The major peak of cmpd (1) was collected and stored frozen
prior to analysis. Mass spectrometry measurements were per-
formed by electrospray on a 12T SolariX Fourier transform mass
spectrometer (Bruker Daltonics) equipped with an inﬁnity cell and
operating in positive mode. Spectra were the sum of 20 mass an-
alyses and collected with a data size of 4 Mword. Agilent tune mix
was used for external calibration. Analysis was achieved with Data
Analysis version 4.4 (Bruker Daltonics).
2.6. Analysis of redox properties of HPLC-fractionated metabolites
For preparative purposes, HPLC fractions (0.5 ml) were collected
and used in peroxidase or H2O2 assays either immediately or after
storage. In the latter case the fractions were frozen in liquid ni-
trogen before storage at 75 C. Since ascorbate degradationFig. 2. HPLC of diketogulonate and its by-products. (a) The DKG preparation was fractionate
monitored simultaneously for absorbance at 210, 250 and 300 nm, and fractions (labelled fr1
(Supplemental Fig. 5), is shown. (b) UV spectrum of the peak containing cmpd (1), eluting at
applied to a new preparation of DKG for 15 min, then the products were fractionated as in (a)
arrows with names in brackets, expected elution positions of the named compounds.products were eluted from the HPLC column in 47 mM H2SO4 (pH
~1), the assays were modiﬁed as follows. The peroxidase activity
assay mixture (1.0 ml) contained (added in the following order;
ﬁnal concentrations are given): 25 mM Na2-succinate, 37 mM
succinate (Naþ) buffer (pH 5.6), 225 ml of the HPLC fraction (if
<225 ml, the remaining volume was added as 47 mM H2SO4),
550 mM ABTS, 250 mM H2O2, and 3.13 ng/ml peroxidase. When an
AAO treatment was included, AAO (1 U/ml; active or boiled) was
added after the HPLC fraction had been mixed with the succinate;
then, after 10 min incubation at 20 C, ABTS and H2O2 were added
and the assay was started by addition of peroxidase.
The assay mixture for non-enzymic H2O2 generation contained
(ﬁnal volume 3.0 ml): 8.3 mM Na2-succinate and 225 ml of HPLC
fraction (if <225 ml, the remaining volume was added as
47 mM H2SO4) and 1 mM CuSO4 (added last). When an AAO pre-
treatment was included, the enzyme (0.7 U/ml) was added after
the HPLC fraction had been mixed with the succinate, and the vials
were incubated for 10 min on a shaker (100 rpm) at 20 C before
addition of CuSO4 (to 1 mM). As a control for the AAO treatment, the
HPLC fraction was treated for 10 min with denatured AAO (10 min
boiling). This treatment was also important to show whether in-
cubation at an increased pH was enough to alleviate the effect of
the compound, i.e. whether the compound was more labile at pH~5
than at pH~1.
H2O2 generated was measured by the XO assay [3,16,24]. Ali-
quots (100 ml) of the reaction mixture were sampled at time points
and immediately added to 1 ml of XO mixture (containing 125 mM
XO, 100 mM D-sorbitol, 250 mM FeSO4, 250 mM (NH4)2SO4 and
25 mM H2SO4). All sample-XO mixtures were incubated for
40 min at room temperature before measurement of A560 against ad by HPLC with 47 mM H2SO4 as eluent, revealing several metabolites. The eluate was
to fr13) were collected. A possible structure for cmpd (1), based on its mass spectrum
11.01 min. (c) Ascorbate oxidase (AAO; 12 U/ml), or denatured enzyme as a control, was
. Absorbance at 250 nm is shown. Solid arrows, nomenclature of signiﬁcant peaks; open
Fig. 3. Selected HPLC fractions from a diketogulonate preparation delay peroxidase
action. ABTS was used as peroxidase substrate. Volume of HPLC fraction added to the
assay: 150 ml. The effect of pretreatment of the fractions with AAO (1 U/assay; þAAO)
or with boiled AAO (þboiled enz) at pH ~5.2e5.6 for 10 min before the peroxidase
activity assay is also shown.
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8.3 mM Na2-succinate þ 1 ml of XO mixture. CuSO4 was observed
not to interfere with the XO assay. A standard curve was prepared
with different concentrations of H2O2 in 1 mM CuSO4. A dilution
series of H2O2 was prepared inwater and a portion of each solution
was adjusted to 1 mM CuSO4 immediately before addition to XO
reagent.
3. Results
3.1. Diketogulonate generates a by-product that reduces O2 to H2O2
and delays peroxidase action on model substrates
DKG, prepared by hydrolysis of DHA, exhibited a prominent
peak of UV absorbance at pH 5.6 (lmax 271e272 nm; [22]. In
contrast, the DHA had negligible absorbance at this wavelength or
at 265 nm (which is the lmax of ascorbate, erythroascorbate and
3,4-enediol-DKGL in neutral solution; Table 1). Since freshly-made
aqueous DKG is stated to have no strong absorption above 225 nm
[36], the observed absorbance at 271e272 nm was probably
attributable to unidentiﬁed DKG degradation products, the major
one of which is here termed cmpd (1).
Similar DKG solutions had been shown to reduce O2 to H2O2
non-enzymically in the presence of a trace of Cu2þ [22]. We now
give evidence that this is due to the presence of cmpd (1). In
addition, we have found that in in-vitro peroxidase assays, the DKG
preparation caused a concentration-dependent lag, presumably
also due to cmpd (1), before the oxidation of a model substrate, o-
dianisidine, became visible (Fig. 1). After this lag, the reaction ve-
locity was similar to (or, in the case of high ‘DKG’ concentrations,
slightly slower than) that of the non-inhibited peroxidase, and the
duration of the lag correlated with the amount of ‘DKG’ added.
These effects, which seem unlikely to be due to DKG itself, are
similar to those exerted by ascorbate [50]. DHA, on the contrary,
showed little inhibition of peroxidase activity.
3.2. Ascorbate oxidase partially inactivates cmpd (1)
Since the UV spectrum of the DKG preparation (lmax 271 nm at
pH 5.6; Fig. 8 of [22] was reminiscent of that of ascorbate (lmax
265 nm at pH 5.6), we explored the possible presence of ascorbate-
like substances. Pre-treatment of the DKG preparation with ascor-
bate oxidase (AAO) diminished but did not abolish the lag period
(Fig. 1). The A271 of the DKG preparation decreased slowly without
any enzyme addition; addition of AAO accelerated this reaction
(Fig. 8 of [22], but it took several minutes before the absorbance
value reached a minimum, and even then some A271 persisted. In
contrast, the A265 of a solution of pure ascorbate reaches zero a few
seconds after AAO addition (Supplemental Fig. 1), conﬁrming that
cmpd (1) is not ascorbate. In a mixture of the DKG preparation and
pure ascorbate, AAO caused a rapid decrease in A265 (due to
ascorbate oxidation) followed by a slower decrease due to cmpd (1)
oxidation (Supplemental Fig. 1); thus it cannot be argued that the
DKG was inhibiting the AAO. Nevertheless, cmpd (1) appears to be
ascorbate-related since AAO has a high speciﬁcity towards L-
ascorbate and related compounds that have a lactone ring with an
adjacent eneediol group such as erythroascorbate [6].
3.3. High-voltage electrophoresis of the crude DKG preparation
As the alkali-generated DKG preparation contained several by-
products [22], we attempted to separate these by electrophoresis
and test them individually for peroxidase action delay
(Supplemental Fig. 2) and non-enzymic H2O2 generation (data not
shown). After electrophoresis at pH 2.0 (Supplemental Fig. 2a), onlyfraction 2 (containing neutral and weakly acidic material) exerted
these effects, and only to a low degree. Thus the only active prin-
ciple detected had clearly separated from DKG itself (a relatively
strong acid, found in fractions 3 and 4). However, the total recov-
ered zones had far less H2O2-generating and peroxidase-delaying
capacity than the crude DKG that had been applied to the
electrophoretogram.
After electrophoresis at pH 3.5 (Supplemental Fig. 2b) or 6.5
(Supplemental Fig. 2c), the only active principle detectedwas found
to have co-migrated with DKG. This could indicate that (i) cmpd (1)
co-migrated with DKG at these pH values, and/or (ii) the cmpd (1)
originally present was degraded during the electrophoresis and
subsequent elution but new cmpd (1) was formed from the eluted
DKG itself.3.4. HPLC of the DKG preparation
On HPLC, freshly prepared crude DKG revealed several peaks of
absorbance at 210 nm (A210 peaks), suggesting carboxylic acids,
esters or lactones, and at least three A250 peaks (suggesting con-
jugated double-bonds; labelled 1, 2 and 3 in Fig. 2). Cmpd (1) was
eluted shortly after the DKG peak, only partially separated from it
(retention times 11.02 and 10.64 min respectively; Fig. 2). We
propose that cmpd (1) showed a pH-dependent absorbance shift,
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respectively (the HPLC eluent was 47 mM H2SO4). This shift would
mirror the behaviour of ascorbate and 3,4-enediol-DKGL, which
have lmax 245 and 265 nm in acidic and neutral solutions respec-
tively [36,48]. Cmpd (1) was again conﬁrmed not to be ascorbate
itself, as this elutes at 13.25 min in this system.
3.5. Ability of HPLC fractions to generate H2O2 and delay peroxidase
action
Fraction 5 (Fig. 2a), which contained the majority of cmpd (1),
was the most effective fraction at delaying peroxidase action on a
model substrate (ABTS; Fig. 3). Other delaying agents were also
detected, e.g. in fractions 8 and 9. A moderate delaying effect was
also observed in fraction 4, which contained most of the DKG
(Figs. 2 and 3). However, since 24% of cmpd (1) eluted in fraction 4,
and because some of the DKG may be further degraded to cmpd (1)
after elution from the column, we conclude that the peroxidase
delaying agent in fraction 4 was cmpd (1), not the DKG itself.
Fractions 4 and 5 also caused non-enzymic H2O2 production in
the presence of O2 and a trace of Cu2þ, fraction 5 again being more
effective (Supplemental Fig. 3). The other HPLC fractions tested,
even those that caused a slight delay in peroxidase activity assays,Fig. 4. Effect of treatment at pH 1 or 6 on the HPLC proﬁle of diketogulonate and its by-prod
H2SO4 and, after storage for 0.5e3.0 h at 0 C, fractioned by HPLC. During each run, absorba
nomenclature of signiﬁcant peaks; open arrows with names in brackets, expected elution pdid not generate H2O2.
3.6. Ascorbate oxidase diminishes the ability of HPLC fractions to
delay peroxidase action and generate H2O2
AAO pre-treatment of the peroxidase-retarding HPLC fractions
(4, 5, 8 and 9; Fig. 2a) diminished their ability to delay peroxidase
action (Fig. 3). Treatment with heat-denatured AAO (i.e., ‘ageing’
the fractions at elevated pH (5.2e5.6) in the absence of active AAO)
also slightly reduced the lag caused by fractions 4, 5, 8 and 9.
However, AAO did not completely destroy the peroxidase delaying
effects of any of these fractions, suggesting either that several
agents were present in each fraction, only some of them being AAO-
oxidisable, or that the AAO generated new products whose
peroxidase-delaying properties were weaker than those of the
initial compounds.
AAO-pretreatment of fractions 4 and 5 also diminished their
ability to non-enzymically generate H2O2 (Supplemental Fig. 3).
3.7. UV-detectable compounds (1), (2) and (3) can be oxidised by
ascorbate oxidase
Since AAO affected the HPLC fractions' effects on H2O2ucts. The DKG, prepared by NaOH treatment of DHA, was adjusted to pH 1 or pH 6 with
nces at (a) 210, (b) 250 and (c) 300 nm were simultaneously monitored. Solid arrows,
ositions of the named compounds.
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which UV-detectable compounds were affected by the AAO treat-
ment. The crude DKG preparation was treated with AAO (active or
denatured) for 15 min and re-run by HPLC. The most remarkable
changes were observed in compounds absorbing at 250 nm
(Fig. 2c). In particular, active AAO strongly diminished the cmpd (1)
peak. A slight decrease was also noticed in the A210 of this peak
(data not shown), suggesting that cmpd (1) is a carboxylic acid or
ester as well as possessing conjugated double bonds. Compounds 2
and 3 also diminished (Fig. 2c; the peak eluting at 15.8 min is
probably the succinate buffer).
3.8. Cmpd (1) is less stable at pH 6 than at pH 1
Since treatment evenwith denatured AAO (at pH ~5.6) modiﬁed
the HPLC proﬁle (Fig. 2c) and the fractions' ability to delay perox-
idase action (Fig. 3) and to promote H2O2 production
(Supplemental Fig. 3), we tested the effect of pH on the stability of
DKG and its by-products. For this work, DKG was prepared by
alkaline hydrolysis of DHA and the reaction was stopped withFig. 5. Effect of pH on the ability of diketogulonate and/or its by-products to delay
peroxidase action. The samples tested were (a) the whole DKG preparation was stored
at 0 C for 0.5e3.0 h at pH ~1 or at pH ~6; and (b) HPLC fractions thereof that had been
collected in 47 mM H2SO4 (pH ~1) as in Fig. 2a. In each case, the samples were then
tested for effect on in-vitro peroxidase action with ABTS as substrate. In (a), the lag
times caused by the whole preparation were very long, so the samples were diluted for
the assay (to ~23 and 46 mM ﬁnal). In (b), with HPLC fractions 4 and 5, undiluted 100-ml
portions were included in 1-ml peroxidase reaction mixtures with Na2-succinate
addition to buffer the pH above 5.H2SO4 either to pH 6 or to pH 1 (Fig. 4). DKG itself, detected at
210 nm, was almost unaffected by storage on ice for 0.5e3 h at pH 1
or 6 (Fig. 4a). When pre-treated at pH 6, instead of pH 1, compounds
(1), (2) and (3) were diminished, little affected and increased
respectively (Fig. 4b). Therefore, if cmpd (1) was the reductant that
delays peroxidase action, then its effect should be weakened by
storage at pH 6.
This predictionwas tested on samples stored at pH 1 or 6 before
HPLC. Pre-treatment of the unfractionated preparation only slightly
diminished its ability to delay peroxidase action regardless of the
pH to which they were adjusted (Fig. 5a), possibly because other
reductants e.g. compound (3) increased after treatment at pH 6
(Fig. 4). However, in HPLC-puriﬁed preparations (fractions 4 and 5),
storage at pH 6 did weaken the effect compared with storage at pH
1, approximately halving the lag period observed before peroxidase
action began (Fig. 5b) [the pH of the peroxidase reactions was
adjusted to >5 with the addition of Na2-succinate to HPLC frac-
tions]. These data strongly support the idea that cmpd (1), the main
250-nm-absorbing compound in fractions 4 and 5, was the major
reductant that delayed peroxidase action on its model substrate.
3.9. Analysis of cmpd (1) by high-voltage paper electrophoresis
HVPE has proved very useful for resolving ascorbatemetabolites
[17,18,38,39]. Partially puriﬁed cmpd (1) obtained by preparative
HPLC with 13 mM TFA as eluent (chosen because it is readily vol-
atile) gave stainable spots on analytical electrophoretograms
(Fig. 6). The HPLC proﬁle with TFA as eluent (Supplemental Fig. 4a)
was broadly similar to that with H2SO4 (Fig. 2a), DKG eluting
slightly before cmpd (1).
The greatest amounts of cmpd (1) were found between 10.5 and
11.25 min (Supplemental Fig. 4b and c). This 0.75-min window of
fractions was pooled, dried in vacuo and re-dissolved in water;
portions were electrophoresed at pH 2.0 and 6.5 and stained with
AgNO3 (Fig. 6), revealing:
 DKG, which is only partially resolved from cmpd (1) by the HPLC
system used;
 compounds C and E (a trace), which are proposed [39] to be
C ¼ 2-carboxy-L-xylonolactone plus 2-carboxy-L-lyxonolactone;
E¼ their de-lactonised product (a dianionic carboxypentonate);
and
 a spot whosemDKG values were 1.22 at pH 2.0 and 1.05 at pH 6.5,
which stained a slightly yellowish brown rather than the greyish
brown usually produced by AgNO3.
Of these possible identities, we have already shown that cmpd
(1) is not DKG itself. Furthermore, we found that cmpd (1) is not C
or E since puriﬁed C and E gave peaks clearly resolved from cmpd
(1) on HPLC (Fig. 7). This was demonstrated when samples of C and
E (eluted from paper after preparative electrophoresis [17]; were
analysed by HPLC with 13 mM TFA as eluent (Fig. 7b), and a sample
containing cmpd (1) was run immediately thereafter (Fig. 7a). C and
E showed major peaks of A210 at 10.1 and 9.2 min respectively, and
only small peaks of A250 (Fig. 7b); in contrast, cmpd (1) showed
greater absorbance at 250 nm and eluted at 10.5 min (Fig. 7a). Thus
cmpd (1) is clearly distinguished from cmpds C and E. Compounds
C and E form from DKG in aqueous conditions [17,39], and the spots
of them seen in Fig. 6 would have formed from the DKG after being
eluted from the column.
We therefore suggest that, of the spots seen in Fig. 6, one with
mDKG values 1.22 and 1.05 at pH 2.0 and 6.5 respectively is likely to
be cmpd (1). Although its structure remains unknown, some of its
ionic properties can be deduced from the electrophoretic mobil-
ities. At pH 6.5, all eCOOH groups are almost fully ionised, so the
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that it has a charge:mass ratio similar to theirs, i.e. 1 negative
charge per ~6 carbon atoms. Furthermore, since the compound
appears to be anionic even at pH 2.0, with amobility exceeding that
of DKG (mDKG ¼ 1.22; Fig. 6a), it is probably a strong acid with a pKa
even lower than that of DKG (predicted pKa z 2.38; http://www.
hmdb.ca/metabolites/HMDB05971).3.10. Mass spectrometry of cmpd (1)
A further sample of cmpd (1), partially puriﬁed by HPLC as in
Supplemental Fig. 4, was analysed by MS in positive mode
(Supplemental Fig. 5). Ion peaks at m/z 159.03164 and 181.01351
were observed, which were absent from the blank. These ions are
interpreted as C6H6O5$Hþ and C6H6O5$Naþ (m/z values respectivelyFig. 6. Analysis of HPLC-enriched cmpd (1) by high-voltage electrophoresis. Cmpd (1) was
analysed by electrophoresis at pH 2.0 (a) or 6.5 (b). Each sample, and the markers, contain
stained in AgNO3. Abbreviations used: EryR, erythrarate (¼meso-tartrate); ThrR, L-threarate (
carboxy-L-xylonolactone and/or 2-carboxy-L-lyxonolactone; E, de-lactonised C; DHA, dehydr
the cmpd (1) preparation are labelled to the right, markers to the left of each electrophoretog
spots in the lane.17 and 12 ppm deviation from theoretical, which is acceptable since
the nearest calibration point was at m/zz 332).4. Discussion
Freshly prepared DKG is reported to have little UV absorbance at
wavelengths above about 225 nm [36]. However, our DKG prepa-
rations rapidly produced a proportion of compound (1), with lmax
271 and 251 nm at neutral and acidic pH respectively. These lmax
values may be compared with those of ascorbate and some of its
previously reported degradation products (Table 1). Cmpd (1)’s
lmax values, and its bathochromic shift when the pH is adjusted
from acidic to neutral, suggest some chemical similarities to
ascorbate. Furthermore, like ascorbate, DHA and 3,4-enediol-DKGL
[48], cmpd (1) was more stable at acidic than neutral pH.partially puriﬁed by HPLC with 13 mM TFA as eluent (see Supplemental Fig. 4), then
ed a trace of Orange G, which was circled in pencil before the other compounds were
¼ L-tartrate); ThrO, threonate; OxT, oxalyl threonate; cOxT, cyclic oxalyl threonate; C, 2-
oascorbic acid; DKG, diketogulonate (prepared by the iodate method). Spots present in
ram. Spots labelled () are contaminants as they are not precisely in line with the other
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and ascorbate, the delaying effect of cmpd (1) on peroxidase action
mimicked that of ascorbate. Ascorbate serves as an anti-oxidant,
scavenging peroxidase-generated phenolic radicals, so that the
oxidation of aromatic substrates becomes visible only when all
ascorbate has been oxidised [50]. Thus, cmpd (1) probably affects
peroxidase action in a similar manner.
In the present work, several metabolites obtained from a DKG
preparation induced the non-enzymic production of H2O2 and
delayed the onset of substrate oxidation in in-vitro peroxidase as-
says. A scheme for ascorbate degradation has been proposed
[17,18,38,39] in which the initial oxidation product, DHA, is either
further oxidised (to oxalyl threonate, cyclic oxalyl threonate and
oxalate þ threonate) or hydrolysed (to DKG and its own down-
stream products C and E). The oxidising branch was proposed to
include, or lead to, three steps that might generate H2O2. On the
other hand, the hydrolytic pathway was not proposed to yield
H2O2; therefore the discovery reported here that DKG by-products,
principally cmpd (1), do generate ROS, probably mainly H2O2, was
of great interest.
Cmpd (1) has two effects which superﬁcially seem contradic-
tory: (a) when present in peroxidase assays it appears to serve as an
anti-oxidant, scavenging phenolic radicals such that the oxidation
of aromatic substrates (o-dianisidine and ABTS) becomes visible
only when all the cmpd (1) has been oxidised, and (b) it non-Fig. 7. Cmpd (1) is not a carboxypentonate. (a) Cmpd (1), puriﬁed by HPLC eluted in 13 mM T
sample containing compounds C and E (carboxypentonates, prepared by alkali treatment of
HPLC in water and monitored by A210 and A250.enzymically reduces O2 to H2O2, the oxidising substrate of peroxi-
dase. Effect (a) would delay peroxidase action, whereas effect (b)
would promote it. Both these effects could have biological signiﬁ-
cance in the plant cell wall. Effect (a) would delay the peroxidase-
catalysed cross-linking of cell-wall phenolics [50], e.g. of ferulate to
diferulates and tyrosine to isodityrosine, thus potentially prevent-
ing wall tightening. Conversely, the H2O2 generated in effect (b) can
non-enzymically lead to the formation of other ROS. In particular,
the hydroxyl radical (OH) is readily formed from H2O2, especially
in the presence of some remaining ascorbate [12], the precursor of
cmpd (1). It is known that OH causes non-enzymic scission of cell-
wall polysaccharides [12,45,52], potentially loosening the primary
cell wall. Preventing wall tightening and promoting wall loosening,
caused by (a) and (b) respectively, are both expected to lead to a
more readily extensible or softer wall. Therefore the two apparently
divergent effects of cmpd (1) may act in an equivalent direction,
both of them facilitating biological processes that depend on a
‘loose’ cell wall such as cell expansion, fruit softening and abscis-
sion. Additionally, similarly to ascorbate, cmpd (1) may inﬂuence
the oxidative burst occurring during pathogen attack, and hence
plant defence responses [41].
The only known source of cmpd (1), potentially exerting such
wall-loosening effects, is DKG d which is formed by the non-
enzymic hydrolysis of apoplastic DHA. DHA can itself be formed
from apoplastic ascorbate, about 50% by endogenous AAO actionFA, was re-run by HPLC in water and the products were detected by A210 and A250. (b) A
DHA and subsequent elution from a preparative electrophoretogram) was also run by
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tionation), and 50% non-enzymically [18]. The ability of apoplastic
AAO to generate monodehydroascorbate and hence DHA, and thus
initiate the DHA / DKG / cmpd (1) pathway with consequent
wall loosening, may explain the hitherto mysterious observation
that AAO activity (which destroys ascorbate) often correlates
positively with rapid plant cell growth, despite the fact that rapid
growth usually correlates with high ascorbate biosynthesis [30].
Cmpd (1) proved highly unstable and we were unable to obtain
it in a form pure enough to provide satisfactory NMR. Nevertheless,
cmpd (1)’s early elution from a Rezex HPLC column [retention time
comparable to those of DKG (Figs. 2a and 4a, Supplemental Fig. 4a)
and oxalate (Fig. 7 of [38]] suggests that it is a relatively strong acid.
Its strongly acidic nature is also indicated by the anionic spot
observed on electrophoresis at pH 2.0 of a sample enriched in cmpd
(1) (Fig. 6). This would exclude various dioxo compounds previ-
ously reported [34] as DKG degradation products such as xylosone,
erythrosone, threosone, and 3-deoxyerythrosone.
MS revealed a compound with the formula C6H6O5, whose Hþ
and Naþ adducts were observed (Supplemental Fig. 5). A potential
structure for C6H6O5 is shown in Fig. 2a. The siting of hydroxy
groups and double-bonds shown is arbitrary, but this suggested
lactone structure somewhat resembles ascorbic acid, which would
account for cmpd (1)’s reducing properties and its susceptibility to
ascorbate oxidase. Such a compound would be expected to ionise
on the oxygen at C-3, giving an electrophoretically mobile anion.
Although it remains unknown by what reaction such a structure
could be formed, the process would involve the DKG (C6H8O7)
serving as an oxidising agent (C6H8O7/ C6H6O5 þ H2O þ [O]) in a
reaction in which some other compound would be oxidised by the
‘[O]’.
We conclude that cmpd (1) is a hitherto unreported acidic
reducing agent produced by oxidation of DKG.
5. Conclusion
Cmpd (1), a product of ascorbate formed via the pathway
ascorbate / dehydroascorbic acid / DKG / cmpd (1), delays
peroxidase action in vitro. The build-up of cmpd (1) in the cell wall
would decrease peroxidase-catalysed scavenging of H2O2 and thus
lead to an accumulation of H2O2 into the apoplast. This, and the
additional H2O2 formed non-enzymically fromO2 by cmpd (1), may
have profound effects on the physiology and further behaviour of
the cells. H2O2 can have direct effects in the cell wall (reviewed in
Ref. [23], or as a signalling molecule it can mediate changes in gene
expression leading to various biological effects [57] and affect
plant-pathogen interactions [41].
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